Preview: India's Max Healthcare rises ahead of quarterly results

Max Healthcare Institute

05/02/2026 05:28

**Shares of Max Healthcare Institute MAXE.NS up 0.3% at 1,028.7 rupees ahead of Q3 results

**Kotak expects Q3 to be a weak quarter; forcasts sequential decline in occupancies and y/y drop in average revenue per occupied bed due to contribution from new units

**Brokerage expects quarterly sales growth to be muted on-year, hit by lower cashless insurance patients for one month, minimal benefit from rate hikes in federal health schemes

**HBSC expects 15.1% revenue growth year-on-year but a 167 bps dip in EBITDA margins on cost drag from newer units

**Stock rated as "buy" on average by 21 analysts; median PT at 1,290 rupees per data compiled by LSEG

**Stock fell 7.4% in 2025, YTD down 1.9%

(Reporting by Mridula Kumar in Bengaluru)

((Mridula.Kumar@thomsonreuters.com;))